Petya cyberattack cost Merck $135 million in revenue

Merck reported a $240 million decrease in sales in its third-quarter financial results, a result of the Petya cyber attack that affected the company. Merck experienced a production shutdown and did not have enough stock to meet the higher demand. Additionally, the company also reported a loss of $135 million in sales in certain markets due to the cyber attack. Overall, Merck’s global sales were down 2 percent from the previous year.